HIV-1 Integrase Inhibitor 1

CAS No. 2146094-22-4

HIV-1 Integrase Inhibitor 1( —— )

Catalog No. M13429 CAS No. 2146094-22-4

A novel compound that disrupts the HIV-1 integrase LEDGF interaction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HIV-1 Integrase Inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel compound that disrupts the HIV-1 integrase LEDGF interaction.
  • Description
    A novel compound that disrupts the HIV-1 integrase LEDGF interaction; produces an ALLINI-like phenotype through engagement of IN sites distinct from the LEDGF pocket.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2146094-22-4
  • Formula Weight
    480.579
  • Molecular Formula
    C26H28N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)NS(=O)(=O)C1=CC=CC=C1C2=CC(=CC=C2)C(=O)NC3=CC=C(C=C3)CCC(=O)O
  • Chemical Name
    3-(4-(2'-(N-(tert-butyl)sulfamoyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Burlein C, et al. ACS Chem Biol. 2017 Nov 17;12(11):2858-2865.
molnova catalog
related products
  • DPC-681

    A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.

  • Amprenavir

    A potent HIV-1 protease inhibitor with IC50 of 80 nM, has mean IC50 of 12 nM against 6 HIV clinical isolates.

  • 3-Deazaadenosine hyd...

    3-Deazaadenosine hydrochloride is an inhibitor of S-adenosylhomocysteine hydrolase (Ki: 3.9 μM). It has anti-inflammatory, anti-proliferative, and anti-HIV activity.3-Deazaadenosine shows the anti-HIV effect and inhibits p24 antigen in peripheral blood mononuclear (PBMCs) cells infected with HIV-1 isolates (A012 and A018, IC50s: 0.15 and 0.20 μM).